Endeavor

Can Tumor Mutations Cause Resistance to Cellular Immunotherapy?

Moffitt study shows certain alterations can indicate poor outcomes for lymphoma patients receiving CAR T-cell therapy

Expanded TIL Therapy Shows Promise for Sarcoma Patients

Moffitt studying whether AYA population will tolerate the therapy well

Can Your Microbiome Impact Cancer?

Dr. Patrick Hwu tackles the answer in this Moffitt Medical Minute.

Immunotherapy Benefits Older Patients as Much as Younger Patients

New study favors expanding use of immunotherapy in older patients

5 Questions on a New Treatment for Acute Lymphoblastic Leukemia

FDA Approves 1st CAR T Therapy for Adults with Acute Lymphoblastic Leukemia

Twelve years and two relapses later, Branden Akens says optimism and a clinical trial helped him start his next chapter

Do You Know the Facts About Sarcoma?

The rare, but treatable, type of cancer affects thousands of Floridians

New Donor Cell Transplant Treatment Shows Promise in Multiple Myeloma

Allogeneic hematopoietic cell transplantation can extend survival for patient when combined with chemotherapy

‘Off the Shelf’ CAR T Shows Promise

New study results find the therapy is effective for certain lymphoma patients